Series B · Healthtech
Orange Health raises $25 million Series B
Bertelsmann India Investments and General Catalyst lead the diagnostics company’s financing.
Orange Health announced a $25 million Series B on June 1, 2022, led by Bertelsmann India Investments and General Catalyst. Accel India, Y Combinator, Good Capital and Uncorrelated Ventures also participated.
The company planned to invest in laboratory capacity, product development and technology, while expanding into new markets and strengthening its team. Launched in December 2020, it had served more than one million customers across Bengaluru and the National Capital Region by the announcement.
Use of funds
Product and technology development
Build laboratories
New market expansion
Team expansion
Funding history
Series B · This round$25M
Equity offering$9.8M